Mis à jour le 21 septembre 2026
Drug discovery of type II transmembrane serine protease inhibitors and adhesion GPCR ligands
Professeur à Université de Sherbrooke
Sherbrooke, Canada
Détails
In collaboration with medicinal chemists and molecular pharmacologists we have developed small peptidomimetic inhibitors for type II transmembrane serine proteases and bioluminescence resonance energy transfer assays to discover novel adhesion GPCR ligands involved in cell signaling.
Organisation
Opportunités similaires
Service
Structural Chemistry & Bioinformatics Services for Vaccine, Antibody, Peptide & Drug Design
Zahed khatooni
Scientist à University of Saskatchewan
Saskatoon, Canada
Coopération de projet
Zahed khatooni
Scientist à University of Saskatchewan
Saskatoon, Canada
Partenariat
Partnering on Vaccine, Antibody, Peptide and Drug Design through Computational Biology
Zahed khatooni
Scientist à University of Saskatchewan
Saskatoon, Canada